Vaxcyte, Inc. (PCVX) Misses Q3 EPS by 32c

Vaxcyte, Inc. (NASDAQ: PCVX) reported Q3 EPS of ($1.56), $0.32 worse than the analyst estimate of ($1.24).

For earnings history and earnings-related data on Vaxcyte, Inc. (PCVX) click here.

You May Also Be Interested In

• Yalla Group Limited (YALA) Reports Q2 EPS of $0.24
• JPMorgan Downgrades Millicom International Cellular SA (TIGO) to Neutral
• RBC Capital Downgrades Hermes International (RMS:FP) (HESAY) to Sector Perform